Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology.
about
Applications of SPR for the characterization of molecules important in the pathogenesis and treatment of neurodegenerative diseasesMicroglial pathologyFollow-up evaluation of cognitive function in the randomized Alzheimer's Disease Anti-inflammatory Prevention Trial and its Follow-up StudyNonsteroidal anti-inflammatory drugs are associated with increased neuritic plaquesPathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesisIntranasal BMP9 Ameliorates Alzheimer Disease-Like Pathology and Cognitive Deficits in APP/PS1 Transgenic Mice.The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy.Sex effects of interleukin-6 deficiency on neuroinflammation in aged C57Bl/6 mice.Can peripheral leukocytes be used as Alzheimer's disease biomarkers?Musculoskeletal pain is associated with incident mobility disability in community-dwelling eldersNSAIDs may protect against age-related brain atrophy.Impact of smoking on cognitive decline in early old age: the Whitehall II cohort study.Ibuprofen attenuates oxidative damage through NOX2 inhibition in Alzheimer's diseaseA critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease.Longitudinal inflammation, cognitive decline, and Alzheimer's disease: a mini-reviewPD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer's disease.Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention.Corticosteroids, but not NSAIDs, are associated with less Alzheimer neuropathology.Does cognitive reserve shape cognitive decline?Reactive glia not only associates with plaques but also parallels tangles in Alzheimer's diseaseUpregulation of select rab GTPases in cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer's disease.Improving the pharmacologic management of pain in older adults: identifying the research gaps and methods to address them.Effects of non-steroidal anti-inflammatory drug treatments on cognitive decline vary by phase of pre-clinical Alzheimer disease: findings from the randomized controlled Alzheimer's Disease Anti-inflammatory Prevention Trial.Overview and findings from the religious orders studyExtensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray studyAutophagy flux in CA1 neurons of Alzheimer hippocampus: Increased induction overburdens failing lysosomes to propel neuritic dystrophy.NSAID Use and Incident Cognitive Impairment in a Population-based Cohort.Inflammation and clinical presentation in neurodegenerative disease: a volatile relationship.Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort.Inflammation and immune system activation in aging: a mathematical approach.Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.Mean Daily Dosage of Aspirin and the Risk of Incident Alzheimer's Dementia in Patients with Type 2 Diabetes Mellitus: A Nationwide Retrospective Cohort Study in Taiwan.An update on the efficacy of non-steroidal anti-inflammatory drugs in Alzheimer's disease.Roles of the prostaglandin E2 receptors EP subtypes in Alzheimer's disease.Mechanisms of action of non-steroidal anti-inflammatory drugs for the prevention of Alzheimer's disease.Modulation of dendritic cell function by PGE2 and DHA: a framework for understanding the role of dendritic cells in neuroinflammation.Epidemiological findings of vascular risk factors in Alzheimer's disease: implications for therapeutic and preventive intervention.Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature.Benefits and pitfalls of cardiovascular medication in seniors.Use of Analgesics (Opioids and Nonsteroidal Anti-Inflammatory Drugs) and Dementia-Related Neuropathology in a Community-Based Autopsy Cohort.
P2860
Q26860077-226CF89B-9997-4584-8684-101C137E665FQ26992285-89C39164-FFF1-4859-B860-EAA4261705A6Q27310286-38D0639F-646A-4AFD-90AB-5F84287A7102Q28476681-37872961-AA46-45B6-B0E8-C2C9D8A8D4DEQ30235369-FF298AD2-F198-4A10-AA5E-E3723C6FA70DQ30362847-7F861162-14FF-4467-9C15-0682D4EF249DQ30668465-3A3A5826-8C3F-41E7-AEEB-8C9934377FF3Q33678988-AC9E3677-CD79-4A5A-8DFC-F24A169211B5Q33689076-BC2766A3-8B71-4C85-933C-9B4911A8FF39Q34145064-8A7BED1E-098F-4941-97EE-11785A720C44Q34151315-FDBDECB4-664C-442A-855B-C765D69D2A44Q34252519-50BB0AB1-19FB-48FB-9F45-716D91623139Q34306241-AEE484FD-4B3C-4D0E-83DD-165D711E6FD1Q34376103-2E634EFD-CF6F-4B28-903B-82177B491885Q34475359-C1DF5AF2-21B6-4FBD-A616-91E256D89840Q34509539-CB574FDE-B600-40CC-AB3E-6FF12C6E455AQ34991223-8BB37849-0A06-4F7A-8E8A-563AF6C1881AQ35087578-25755D4E-5279-472B-B21A-CDFCF443F246Q35154095-77E29114-A990-4042-9FE6-AC75AAE907DCQ35167904-4692EFCD-2FD6-4FD6-B0D6-735816713B1FQ35186435-9A596371-9B15-44D6-B357-D76AC7E4A0BCQ35214415-CDFF798E-8335-4F50-A1E4-46C18FAE3443Q35523832-35421647-B5DE-40B5-B6EB-831CDC6F2C9FQ36130996-BFF267AD-B676-4979-9230-31F45812DFEFQ36164195-1DFA74C8-C25F-442C-81EC-06E0AA0FF118Q36182739-688403B3-0803-4BAC-917D-191BFB701C1CQ36348370-3019DFAF-A3EF-4833-8BE0-B7E5AB0AD108Q37069901-AA9C65C1-E168-49ED-A89B-74B816EA4EF0Q37213692-2D038CCC-C44D-49A2-ABA2-F54D06663AC5Q37322037-25BFF495-9ECF-497F-99E2-16E76A753A8FQ37331433-DB25BF90-FDCB-4E31-B8AD-9282246CB919Q37404793-B5018338-F167-4F81-9168-05C6FD5CCC1CQ37546119-6EB4C23F-4F87-4192-B4EC-363C719E9656Q37681315-A5C44A5F-9D6D-4F07-86FB-B39CAD3E7760Q37703299-DF6E5223-225B-4FCC-A928-4D014AB16DBAQ37909028-F64A6B56-A537-4ECB-9744-DE91992015ACQ37947688-225BB6D7-8E5D-431E-9E13-A34621DBFA33Q37982377-3D86B96E-C79D-4D52-B97D-147F138A3E1FQ38120998-2860A6E7-D000-4C24-B676-A3DA06999B22Q38814696-31FCE6FB-5948-47B7-8E0E-1081850D25FA
P2860
Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology.
@en
Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology.
@nl
type
label
Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology.
@en
Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology.
@nl
prefLabel
Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology.
@en
Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology.
@nl
P2093
P1433
P1476
Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology.
@en
P2093
D A Bennett
F Grodstein
J A Schneider
J L Bienias
R S Wilson
Z Arvanitakis
P304
P356
10.1212/01.WNL.0000313813.48505.86
P407
P577
2008-06-01T00:00:00Z